L-Theanine Inhibits Chemoresistance of Lung Cancer Cells to Cisplatin by Regulating STAT3/NOTCH1-BMAL1 Signaling
Frontiers in Bioscience-Landmark · 21.06.2024 · 29 (6)
DOI: 10.31083/j.fbl2906226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 21.06.2024. Verfasst von Wenjing Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, 201399 Shanghai, China. Hauptthemen laut MEDLINE: Glutamates, Drug Resistance, Neoplasm, Lung Neoplasms, Cisplatin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pudong new area Science, Technology and Economy Commission.
Abstract (Originalsprache)
Background
L-Theanine, a nonproteinogenic amino acid derived from green tea, is being recognized as an anti-cancer candidate. However, it’s roles in the development of cancer chemoresistance is still unknown and the molecular mechanism is urgently to be explored.
Methods
The effects of L-Theanine on lung cancer chemoresistance were validated by Cell Counting Kit-8 (CCK-8) assay, transwell assay, and in vitro tumor spheroid formation assay; the expression of proteins was detected by using polymerase chain reaction (PCR) and western blotting. RNA-sequencing (RNA-seq) and bioinformatics analysis were used to identify differentially expressed genes induced by L-Theanine. BMAL1 knockdown and overexpression were constructed by using a lentivirus-mediated transfection system.
Results
L-Theanine improved the chemoresistance to cis-diamminedichloroplatinum (DDP) and inhibited stemness of DDP-resistant lung cancer cells but not non-resistant lung cancer cells. The results from RNA-seq analysis showed that STAT3/NOTCH1 pathway was a potential dominant signaling involved in L-Theanine improving the chemoresistance in DDP-resistant lung cancer. Mechanistically, L-Theanine impeded migration and stemness activation of DDP-resistant lung cancer cells via regulating the expression of STAT3/NOTCH1/BMAL1 signaling-induced stemness markers as well as inhibiting the expression levels of drug resistance-related genes. In addition, a combination of L-Theanine and Stat3 blockade synergistically improved the chemoresistance in DDP-resistant lung cancer.
Conclusion
L-Theanine improves the chemoresistance by regulating STAT3/NOTCH1/BMAL1 signaling, reducing stemness, and inhibiting the migration of DDP-resistant lung cancer cells. The finding might provide some evidence for therapeutic options in overcoming the chemoresistance in cancers, including lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, 201399 Shanghai, China.
- Department of Respiratory Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 201399 Shanghai, China.
Förderung
- Pudong new area Science, Technology and Economy Commission
Zitieren
APA
Jin, W., Su, L., You, H., Dong, Z., Liu, M., & Zhou, C. (2024). L-Theanine Inhibits Chemoresistance of Lung Cancer Cells to Cisplatin by Regulating STAT3/NOTCH1-BMAL1 Signaling. Frontiers in Bioscience-Landmark, 29(6). https://doi.org/10.31083/j.fbl2906226
Vancouver
Jin W, Su L, You H, Dong Z, Liu M, Zhou C. L-Theanine Inhibits Chemoresistance of Lung Cancer Cells to Cisplatin by Regulating STAT3/NOTCH1-BMAL1 Signaling. Frontiers in Bioscience-Landmark. 2024;29(6). doi:10.31083/j.fbl2906226
BibTeX
@article{Jin2024,
author = {Jin, Wenjing and Su, Ling and You, Hong and Dong, Zhouyu and Liu, Min and Zhou, Chao},
title = {L-Theanine Inhibits Chemoresistance of Lung Cancer Cells to Cisplatin by Regulating STAT3/NOTCH1-BMAL1 Signaling},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
volume = {29},
number = {6},
doi = {10.31083/j.fbl2906226}
}
EUVIMED